MediPharm Labs Announces Increased Management Shareholdings and Stock Option Grant
TORONTO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV:LABS; OTCQB:MLCPF) (the “Company” or “MediPharm Labs”), a specialized, research-driven cannabis extraction business, fully licensed under the Cannabis Act (Canada) focused on downstream secondary extraction methodology, distillation, ... [Read]
MediPharm Labs Signs Large Multi-Year Cannabis Extraction Agreement With TerrAscend Marking Strong Start to 2019
TORONTO, Jan. 08, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV:LABS; OTCQB:MLCPF) (the “Company” or “MediPharm Labs”), a specialized, research-driven cannabis extraction business, fully licensed under the Cannabis Act (Canada) focused on downstream secondary extraction methodology, distillation, ... [Read]
MediPharm Labs Commences Trading in United States on OTCQB Market Under Symbol MLCPF
TORONTO, Jan. 07, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV:LABS) (OTCQB:MLCPF) (the “Company” or “MediPharm Labs”), a specialized, research-driven cannabis extraction business, fully licensed under the Cannabis Act (Canada) focused on downstream secondary extraction methodology, distillation, ... [Read]